Fastest-Growing Companies

America's fastest growing companies ranked by stock growth and state.

3 of 100
Questcor Pharmaceuticals
Questcor Pharmaceuticals
3
Financials: Latest Results
Rank: 3
3-year average
Revenue Growth: 85%
Profit Growth: 107%
Total Return: 66%

You’ve heard of so-called “garage sale millionaires”—folks who stumble upon thousand-year-old Chinese artifacts priced $2 million under market value? Questcor Pharmaceuticals had just that kind of luck back in 2001 when it bought anti-inflammatory drug Acthar Gel -- a drug made from the pituitary glands of pigs and approved by the FDA in 1952 -- for the bargain price of $100,000.

Questcor acquired the rights in 2001, and since 2007 has upped its price from $1,650 a vial to $28,000 today. The company’s stock has surged alongside the ascending rates.

Acthar is currently approved for 19 indications. Questcor prescribes it for rare infantile spasms, but the company’s exponential growth is owing to expanded prescriptions for multiple sclerosis, nephrotic syndrome, and, most recently, rheumatologic conditions. Sales for the second quarter reached $185 million, a 64% increase year-over-year. --S.G.

Revenues ($ millions): 548
Net Income ($ millions): 198.2
Sector: Health Care
What businesses do you think are primed to grow in this economy?
To qualify, a company-domestic or foreign-must be trading on a major U.S. stock exchange; report data in U.S. dollars; file quarterly reports with the SEC; have a minimum market... More
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.